Advances in Ophthalmology

Advanced and comprehensive eye care from New York’s #1 Hospital.

The Edward Harkness Eye Institute at NewYork-Presbyterian/Columbia University Irving Medical Center and the Department of Ophthalmology at NewYork-Presbyterian/Weill Cornell Medical Center offer patients the most advanced, comprehensive, and effective eye care. Our dedicated physicians use the latest advances in diagnostic technology and therapy to prevent, detect, and treat every conceivable disorder of the eye. This approach to ophthalmology is combined with a commitment to a wide range of clinical specializations.

image of nyp queens building

Residency Program at NewYork-Presbyterian Queens

The NewYork-Presbyterian/Weill Cornell Medical Center Ophthalmology Residency Program fosters the development of outstanding clinicians and surgeons who possess the skills necessary to expertly diagnosis and manage the full spectrum of ophthalmic disease.

image of harlem street area in nyc

Residency Program at NYC Health + Hospitals/Harlem

Through the collaboration with NYC Health + Hospitals/Harlem, ophthalmology residents broaden their experience with exposure to a different hospital system, a wide variety of patients and ocular disease, and a more severe spectrum of disease.

image of a surgical assistant turning on equipment in an operating room

Breaking Barriers to Eye Care in Underserved Communities

Driven by a commitment to providing equal access to eye care, NewYork-Presbyterian’s ophthalmology residents are providing comprehensive eye care in Central Harlem, Queens, and at community outreach clinics throughout NYC.

image of a doctor displaying a model of a human eyeball

Community-Based Initiatives in Vision Care

Our residents take part in community-based initiatives to provide screenings at public housing developments and collaborate with programs to provide care to uninsured or underinsured individuals and families.

image of a patient wearing a mask getting eye exam

New COVID-era Eye Care Paradigms

As front-line healthcare workers continue to battle the pandemic, the Department of Ophthalmology at NewYork-Presbyterian/Columbia University Irving Medical Center is developing new COVID-era eye care paradigms to meet the challenges facing clinicians and patients.

image of a group of medical staff wearing masks

Columbia Ophthalmology Residency - Innovation and New Opportunities

Since mid-March, the ophthalmology residency program at NewYork-Presbyterian/Columbia University Irving Medical Center has shared dozens of lectures, accessible to trainees across the enterprise and throughout the country.

image of doctor and patient wearing masks talking

Surmounting Challenges and Seizing Opportunities of the COVID-19 Pandemic

With mounting concern that ophthalmologists may be at higher risk of infection, NewYork-Presbyterian’s ophthalmologists are creating new paradigms of care to protect physicians and staff while restoring eyesight and quality of life to our patients.

image of doctors performing eye surgery in an OR

Advancing the Boundaries of Innovation in Ophthalmic Surgery

Harnessing decades of clinical experience and the latest developments in cutting-edge surgical technology, the Ophthalmology program at NewYork-Presbyterian/Weill Cornell Medical Center is advancing the boundaries of innovation in the treatment of complex eye disorders.

image of monitor and program used during eye surgery

Spotlight on Ophthalmic Surgery Innovations

Innovations include: K-Pro for Corneal Repair, Stereoscopic 3D “Heads Up” Digital Visualization System, Amniotic Membrane Application for Severe Ocular Surface Disease, OculoPlastics Expertise for Transorbital Neurosurgery, & PROSE for Complex Corneal Disease.

vector illustration of dna

Realizing the Vision of Precision Ophthalmology™

After decades of pioneering research and clinical achievements, we are making groundbreaking advances in Precision Ophthalmology. Defined as customized genetic, diagnostic, and translational clinical care, Precision Ophthalmology uses a patients’ genetic profile to tailor treatment designed for them.

image of doctors and nurses in an operating room looking at a monitor during eye surgery

Strength in Collaboration: Columbia and Weill Cornell Ophthalmology at NYP

Columbia and Weill Cornell ophthalmologists propelled the transformative growth of the Ophthalmology services at NewYork-Presbyterian by providing advanced treatment for eye diseases and unmatched research and educational opportunities for the leaders of tomorrow.

image of Dr. Simon John

Glaucoma and Genetics Come Into Focus

Dr. John shares his groundbreaking research on the molecular basis of glaucoma, uniting engineering and technology with molecular, genetic, and physiologic methods to identify the genes and molecular mechanisms underlying this neurodegenerative disease.

image of Dr. Ashley Brissette and Dr. Kimberly C. Sippel

Elevating Precision and Safety in Cataract Surgery

With the addition of femtosecond laser for cataract extraction and two innovative optical systems for measuring the refractive power of the eye during surgery itself, NewYork-Presbyterian/Weill Cornell Medical Center is able to offer patients visual results that have been documented to exceed national averages.

image of operating room

Fulfilling a Vision for Superior Ophthalmic Care

The partnership between NewYork-Presbyterian and Weill Cornell Medicine has propelled the growth of the Department of Ophthalmology at NewYork-Presbyterian/Weill Cornell Medical Center, which is transforming ophthalmic surgery with our focus on advanced technology and extraordinary facilities.

image of Precision Ophthalmology 2020 Applied Genetics pdf cover

Precision Ophthalmology 2020

A leading international center for the management of sight-threatening disorders, the Department of Ophthalmology at Columbia University Irving Medical Center is continuing the tradition of innovation with Precision Ophthalmology 2020.

image of Megan Soucy and Dr. Jeffrey M. Liebmann

Glaucoma: Accelerating Genetic Discoveries for Clinical Applications

With the support of a major award from The Brown Foundation, Dr. Jeffrey M. Liebmann and his team have launched the Brown Glaucoma Genetics Initiative, a continuum of investigative and therapeutic projects with the aim of developing treatments for specific subtypes of the disease.

Newsletters for Medical Professionals

2021 Issue 1

2019 Issue 1

2018 Issue 1

2017 Issue 1

2016 Issue 3

Spring 2016

Fall/Winter 2015

Summer 2015

November/December 2014